CD4 c.92G>C ;(p.G31A)

Variant ID: 12-6909515-G-C

NM_000616.4(CD4):c.92G>C;(p.G31A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.

Ebiomedicine
Garcia-Bates, Tatiana M TM; Palma, Mariana L ML; Anderko, Renee R RR; Hsu, Denise C DC; Ananworanich, Jintanat J; Korber, Bette T BT; Gaiha, Gaurav D GD; Phanuphak, Nittaya N; Thomas, Rasmi R; Tovanabutra, Sodsai S; Walker, Bruce D BD; Mellors, John W JW; Piazza, Paolo A PA; Kroon, Eugene E; Riddler, Sharon A SA; Michael, Nelson L NL; Rinaldo, Charles R CR; Mailliard, Robbie B RB; ,
Publication Date: 2021-01

Variant appearance in text: CD4: G31a
PubMed Link: 33450518
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.

Traffic (Copenhagen, Denmark)
Van Puyenbroeck, Victor V; Pauwels, Eva E; Provinciael, Becky B; Bell, Thomas W TW; Schols, Dominique D; Kalies, Kai-Uwe KU; Hartmann, Enno E; Vermeire, Kurt K
Publication Date: 2020-02

Variant appearance in text: CD4: G31A
PubMed Link: 31675144
Variant Present in the following documents:
  • Main text
View BVdb publication page



New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Biochemical Pharmacology
Kleist, Andrew B AB; Getschman, Anthony E AE; Ziarek, Joshua J JJ; Nevins, Amanda M AM; Gauthier, Pierre-Arnaud PA; Chevigné, Andy A; Szpakowska, Martyna M; Volkman, Brian F BF
Publication Date: 2016-08-15

Variant appearance in text: CD4: G31A
PubMed Link: 27106080
Variant Present in the following documents:
  • Main text
View BVdb publication page